BRIACELL THERAPEUTICS CORP (BCTX)
CA10778Y3023 - Common Stock
| MRQ (2024-1-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.24M | 21.25M | 41.04M | 57.27M | 19.20K | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 30.15K | 18.87K | 24.10K | 12.57K | 20.35K | |||
| Other Current Assets | 5.47M | 5.68M | 1.28M | 516.89K | 196.79K | |||
| Total Current Assets | 11.74M | 26.95M | 42.35M | 57.80M | 236.36K | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | N/A | |||
| Investments And Advances | 281.66K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Intangibles | 207.43K | 215.07K | 230.34K | 245.61K | 235.81K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 489.09K | 215.07K | 230.34K | 245.61K | 235.81K | |||
| TOTAL ASSETS | 12.23M | 27.16M | 42.58M | 58.04M | 472.17K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 225.81K | |||
| Accounts Payable | 3.92M | 1.80M | 941.09K | 556.80K | 3.36M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.92M | 1.80M | 941.09K | 556.80K | 3.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 25.99K | 140.96K | |||
| Other Non-Current Liabilities | 16.62M | 29.14M | 31.31M | 29.79M | N/A | |||
| Total Non-Current Liabilities | 16.38M | 29.14M | 31.31M | 29.82M | 140.97K | |||
| TOTAL LIABILITIES | 20.30M | 30.94M | 32.25M | 30.37M | 3.72M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -85.95M | -80.65M | -60.35M | -29.14M | -14.21M | |||
| Additional Paid In Capital | 8.42M | 7.42M | 5.23M | 2.18M | N/A | |||
| Minority Interest | -205.11K | N/A | N/A | N/A | N/A | |||
| Common Shares | 69.59M | 69.59M | 65.59M | 54.77M | 11.09M | |||
| Other Shareholders' Equity | -138.68K | -138.68K | -138.68K | -138.68K | -125.36K | |||
| Shares Outstanding | 15.98M | 15.98M | 15.52M | 15.27M | 721.96K | |||
| Tangible Book Value per Share | -0.52 | -0.25 | 0.65 | 1.80 | -4.83 | |||
| Total Shareholders' Equity | -8.07M | -3.78M | 10.33M | 27.67M | -3.25M | |||
| TOTAL LIABILITIES AND EQUITY | 12.23M | 27.16M | 42.58M | 58.04M | 472.17K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | -0.11 | |||
| Current Ratio | 2.99 | 14.96 | 45.00 | 103.80 | 0.07 | |||
| Return On Assets (ROA) | -103.08% | -74.74% | -63.04% | -23.80% | -770.51% | |||
| Return On Equity (ROE) | N/A | N/A | -259.84% | -49.93% | N/A | |||
All data in USD